We are live on ! Find out more
ENZ

Enzo Biochem, Inc.
ENZ

Delisted

ENZ was delisted on the 17th of April, 2025.

Back to rankings

89 hedge funds and large institutions have $93.6M invested in Enzo Biochem, Inc. in 2015 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 24 increasing their positions, 22 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

90% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 10

49% more capital invested

Capital invested by funds: $62.8M → $93.6M (+$30.8M)

9% more funds holding

Funds holding: 82 → 89 (+7)

9% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 22

0% more call options, than puts

Call options by funds: $415K | Put options by funds: $413K

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
89
Holders Change
+7
Holders Change %
+8.54%
% of All Funds
2.33%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
19
Increased
24
Reduced
22
Closed
10
Calls
$415K
Puts
$413K
Net Calls
+$2K
Net Calls Change
+$90K

Top Buyers

Rank Fund Capital Flow
1
GIM
Granahan Investment Management
Massachusetts
+$3.37M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$2.17M
3
GGHC
Gilder Gagnon Howe & Co
New York
+$1.63M
4
TC
TFS Capital
Pennsylvania
+$1.54M
5
Renaissance Technologies
Renaissance Technologies
New York
+$591K

Top Sellers

Rank Fund Capital Flow
1
ClearBridge Investments
ClearBridge Investments
New York
-$1.57M
2
Wellington Management Group
Wellington Management Group
Massachusetts
-$1.45M
3
Millennium Management
Millennium Management
New York
-$1.05M
4
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance)
Ontario, Canada
-$763K
5
LSVM
Lone Star Value Management
Connecticut
-$633K
Name Holding Trade Value Shares
Change 		Change in
Stake
Northern Trust
26
Northern Trust
Illinois
$440K +$17.2K +4,078 +4%
Morgan Stanley
27
Morgan Stanley
New York
$437K +$25.2K +5,956 +7%
BFA
28
BlackRock Fund Advisors
California
$427K +$18.8K +4,447 +5%
Deutsche Bank
29
Deutsche Bank
Germany
$355K +$285K +67,428 +578%
Two Sigma Investments
30
Two Sigma Investments
New York
$338K +$317K +75,058 New
OAM
31
Oxford Asset Management
United Kingdom
$319K +$298K +70,474 New
KCM
32
Kempner Capital Management
Texas
$315K – – –
AAP
33
Ardsley Advisory Partners
Connecticut
$293K -$443K -105,000 -62%
Citadel Advisors
34
Citadel Advisors
Florida
$263K +$193K +45,595 +353%
California Public Employees Retirement System
35
California Public Employees Retirement System
California
$256K – – –
Susquehanna International Group
36
Susquehanna International Group
Pennsylvania
$236K +$141K +33,308 +175%
UBS Group
37
UBS Group
Switzerland
$214K -$874 -207 -0.4%
SIM
38
Spark Investment Management
New York
$209K +$196K +46,500 New
BCM
39
Bluefin Capital Management
New York
$208K +$195K +46,182 New
RFC
40
Russell Frank Company
Washington
$207K +$190K +45,081 New
Charles Schwab
41
Charles Schwab
California
$198K – – –
EEG
42
E.E. Geduld
$180K +$169K +40,000 New
CCM
43
Coe Capital Management
Illinois
$179K -$369K -87,300 -69%
RCM
44
Rotella Capital Management
Washington
$176K +$165K +39,122 New
LCM
45
Leisure Capital Management
California
$165K +$3.71K +878 +2%
CCMH
46
Cornerstone Capital Management Holdings
New York
$154K -$41.8K -9,900 -22%
CS
47
Credit Suisse
Switzerland
$144K +$135K +31,969 New
Walleye Trading
48
Walleye Trading
New York
$130K +$114K +26,900 +1,345%
BG
49
BlackRock Group
United Kingdom
$128K – – –
Wells Fargo
50
Wells Fargo
California
$114K +$105K +24,885 +4,283%
1
2
3 4

ENZ Hedge Fund Activity: Q4 2015 in Review

89 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q4 2015, worth a combined $93.6M — up 49% from $62.8M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new ENZ positions and 10 closed out — a net gain of 9 holders — while 24 added to existing stakes and 22 trimmed.

The largest buyer was Granahan Investment Management, adding an estimated $3.37M. The largest seller was ClearBridge Investments, cutting an estimated $1.57M.

  • 89 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q4 2015, up from 82 in Q3 2015.
  • Funds reported $93.6M of Enzo Biochem, Inc. stock for Q4 2015, up 49% quarter-over-quarter.
  • 19 funds opened new Enzo Biochem, Inc. positions in Q4 2015 and 10 closed out, a net change of +9 holders.
  • The largest Enzo Biochem, Inc. buyer in Q4 2015 was Granahan Investment Management, an estimated $3.37M added.
  • The largest Enzo Biochem, Inc. seller in Q4 2015 was ClearBridge Investments, an estimated $1.57M sold.

Based on aggregated 13F filings for Q4 2015.